The Cigna Group (NYSE: CI) saw a notable uptick in its stock value, rising by 1.97% to reach $327.58 despite recent insider selling. Eric P. Palmer, the EVP of Enterprise Strategy at Cigna Group, sold 5,684 shares of company stock, totaling $1,847,300 at a price of $325.00 per share, as reported in a recent SEC filing.
Even so, the strong momentum brought forth by recent advancements inside the firm has not been eclipsed by this insider selling. According to JUST Capital and CNBC’s Most JUST Companies ranking, Cigna Group has risen 10 places from the previous year to be acknowledged as the sixth-ranked firm in America for its excellent corporate citizenship.
With this recognition, Cigna Group has been recognized for its commitment to supporting clients, associates, communities, and the environment for five years running. It also leads the healthcare sector in corporate citizenship for the second year running. As it works to improve health outcomes via programs that are equitable, accessible, and sustainable, corporate citizenship continues to be CI’s primary priority.
Acknowledgments like the JUST 100 list function as crucial yardsticks for the organization’s advancement and bolster its dedication to accomplishing predetermined goals. The Cigna Group’s efforts are focused on improving the health and well-being of its stakeholders through the four interconnected pillars of “Healthy Workforce, Healthy Company, Healthy Environment, Friendly Society.”
Cigna Group has announced a definitive deal with Health Care Service Corporation (HCSC), in addition to its commitment to corporate social responsibility. Cigna Group will sell its Medicare Advantage, Medicare Part D, Cigna Supplemental Benefits, and CareAllies operations to HCSC for about $3.7 billion.
A four-year services agreement between Cigna Group and HCSC was reached as part of the arrangement. After the transaction is completed, Evernorth Health Services, a Cigna Group subsidiary, will continue to offer pharmacy benefit services to the Medicare companies. It is anticipated that the transaction would conclude in the first quarter of 2025, pending regulatory clearances and usual closing requirements.
